Publicaciones en colaboración con investigadores/as de University Medical Center Hamburg-Eppendorf (19)

2023

  1. ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer

    Annals of Oncology, Vol. 34, Núm. 8, pp. 645-659

2022

  1. Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical Trial

    JAMA Oncology, Vol. 8, Núm. 7, pp. 1047-1052

2021

  1. COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms

    Molecular Systems Biology, Vol. 17, Núm. 10

  2. Expert Discussion: Highlights from the San Antonio Breast Cancer Symposium, San Antonio, December 8-11, 2020

    Breast Care

  3. Heterozygous ANKRD17 loss-of-function variants cause a syndrome with intellectual disability, speech delay, and dysmorphism

    American Journal of Human Genetics, Vol. 108, Núm. 6, pp. 1138-1150

  4. Non-productive angiogenesis disassembles Aß plaque-associated blood vessels

    Nature Communications, Vol. 12, Núm. 1

  5. Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial

    The Lancet Oncology, Vol. 22, Núm. 4, pp. 499-511

2020

  1. ASCO 2020

    Breast Care

  2. Oncological care organisation during COVID-19 outbreak

    ESMO Open, Vol. 5, Núm. 4

2019

  1. ATTAIN: Phase III study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer and brain metastases

    Future Oncology, Vol. 15, Núm. 19, pp. 2211-2225

2017

  1. Insulin regulates astrocytic glucose handling through cooperation with IGF-I

    Diabetes, Vol. 66, Núm. 1, pp. 64-74

2016

  1. Analysis of plasminogen genetic variants in multiple sclerosis patients

    G3: Genes, Genomes, Genetics, Vol. 6, Núm. 7, pp. 2073-2079

  2. The insulin-like growth factor I receptor regulates glucose transport by astrocytes

    GLIA, Vol. 64, Núm. 11, pp. 1962-1971

2015

  1. Genome-wide significant association with seven novel multiple sclerosis risk loci

    Journal of Medical Genetics, Vol. 52, Núm. 12, pp. 848-855

2014

  1. HLA-Bâ27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitope

    Journal of Hepatology, Vol. 60, Núm. 1, pp. 22-29

2013

  1. Fine Mapping and Functional Analysis of the Multiple Sclerosis Risk Gene CD6

    PLoS ONE, Vol. 8, Núm. 4

2011

  1. Measuring use of services for mental health problems in epidemiological surveys

    International Journal of Methods in Psychiatric Research, Vol. 20, Núm. 3, pp. 182-191

2006

  1. Introduction

    Journal of Acquired Immune Deficiency Syndromes

1993

  1. Induction of axonal growth by heterophilic interactions between the cell surface recognition proteins Fll and Nr-CAM/Bravo

    Neuron, Vol. 11, Núm. 6, pp. 1113-1122